Thallium-201 SPECT as response parameter for PCV chemotherapy in recurrent glioma

Journal of Neuro-Oncology

Volumn 40, Issue 3, 1998, Pages 251-255

  Roesdi, M F ^a,b   Postma, T J ^a   Hoekstra, O S ^a   Van Groeningen, C J ^a   Wolbers, J G ^a   Heimans, J J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Chemotherapy; Recurrent glioma; Response parameter; Thallium 201 SPECT

Indexed keywords

LOMUSTINE; PROCARBAZINE; THALLIUM 201; VINCRISTINE;

ARTICLE; CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE COURSE; DRUG RESPONSE; FEMALE; FOLLOW UP; GLIOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PATIENT MONITORING; RADIOLOGY; RECURRENT CANCER; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CISPLATIN; CYCLOPHOSPHAMIDE; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VINDESINE;

EID: 0032411325     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006090807678     Document Type: Article

References (15)

1. Levin VA, Edwards MS, Wright DC, Seager ML, Pischer Schimberg T, Townsend JJ, Wilson CB: Modified procarbazinc, CCNU and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors. Cancer Treat Rep 64: 237-241, 1980
2. Cairncross JG, Macdonald DR: Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 23: 360-364, 1988
3. Macdonald DR, Cascino TL, Schold Jr SC, Cairncross JG: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8: 1277-1280, 1990
4. Slizofsky WJ, Krishna L, Katsctos CD, Black P, Miyamoto C, Brown SJ, Vender J, Chevres A, Khan AS, McEvan J, Dadparvar D: Thallium imaging for brain tumors with results measured by a semiquantitative index and correlated with histopathology. Cancer 74: 3190-3197, 1994
5. Kosuda S, Fujii H, Aoki S, Suzuki K, Tanaka Y, Nakamura O, Shidara N: Reassessment of quantitative thallium-201 brain SPECT for miscellaneous brain tumor. Ann of Nucl Med 4: 257-263, 1993
6. Mountz JM, Raymund PA, Mckeever PE, Modell JG, Hood TW, Barthel LK, Stafford-Schuck KA: Specific localization of Thallium 201 in human high-grade astrocytoma by microautoradiography. Cancer Res 49: 4053-4056, 1989
7. Kaplan WD, Takvorian T, Morris JH, Rumbaugh CL, Connoly BT, Atkins HL: Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med 28: 47-52, 1987
8. Cairncross G, Macdonald D, Ludwin S, Lee D, Cascino T, Buckner J, Fulton D, Dropcho E, Steward D, Schold Jr C, Wainman N, Eisenhauer E: Chemotherapy for anaplastic oligodendroglioma, J Clin Oncol 12: 2013-2021, 1994
9. Fine HA, Dear KB, Loeffler JS: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585-2597, 1993
10. Mason WP, DeAngelis LM: Procarbazine, CCNU, Vincristine (PCV) chemotherapy (CT) for benign oligodendroglionias. Neurology 44: 262-263, 1994
11. Levin VA, Silver P, Hannigan J: Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarhazine and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 18: 321-324, 1990
12. Doom GC, Hecht S, Brant-Zawadzki M, Berthiaume Y, Norman D, Newton TH: Brain radiation necrosis: MR imaging. Radiology 158: 149-155, 1986
13. Brada M, Sharpe G: Chemotherapy of high-grade gliomas, Beginning of a new era or the end of the old? Eur J Cancer 32A: 2193-2194, 1997
14. Black KL, Emerick T, Hoh CK, Hawkins RA, Mazziota J, Becker DP: Thallium-201 SPECT and positron emission tomography equal predictors of glioma grade and recurrence. Neurol Res 16: 93-96, 1994
15. Lorberboym M, Mandell LR, Mosesson RE, Gcrmano I, Lou W, DaCosta M, Linzer DG, Machac J: The role of Thallium-201 uptake and retention in intracranial tumors after radiotherapy. J Nucl Med 38: 223-226, 1997